News Commentary | February 25, 2020
Maven is a telehealth app designed for women, providing services from more than 20 specialties, such as mental health, dermatology, and maternity care, that recognizes that women are usually the healthcare decision‑makers of the family. By recognizing this role, the app makes it easy for women to ... Not part of subscription
News Commentary | April 14, 2020
Telehealth companies are in high demand right now due to the COVID‑19 crisis. However, there are significant limits to the video/text chat‑only options offered by most leading telehealth providers. Metrics like temperature, blood pressure, and heart rate are normal parts of checkups and primary care... Not part of subscription
News Commentary | May 14, 2020
Much has been made of ventilator shortages in fighting COVID‑19; however, a lack of skilled respiratory staff continues to place an overwhelming burden on the current staff. While telehealth is often perceived as video conferencing for patients to receive care from their homes, prior to COVID‑19, ... To read more, click here.
by Danielle Bradnan
This is an enormous deal in terms of both money and the market context of telehealth. It brings juggernaut digital therapeutic Livongo Health into the fold of Teladoc, critically augmenting the more traditional video conferencing approach where Teladoc has been a market leader with remote monitoring and mHealth capabilities. This is important for bolstering Teladoc against the video conferencing-based telehealth bubble that is likely to burst in the U.S. due to a renewed lack of reimbursement and all but ensures Teladoc Health's primacy in the telehealth space. Clients looking to compete in the telehealth space need to move now, focusing on acquisition targets that lean into the remote monitoring and mHealth capabilities of telehealth.
For the original news article, click here .